Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Enzene Biociences Ltd, Plot No A22, A/1/2, MH, IN
Williamson offers experience building innovative life sciences companies and delivering strong commercial and operational outcomes.
By: Charlie Sternberg
New alliance is dedicated to advancing lipid nanoparticle (LNP) technology and accelerating the development of next-generation therapeutics.
The site is also expanding its High Potency Active Pharmaceutical Ingredient and Antibody Drug Conjugate capacity.
By: Rachel Klemovitch
Collaboration complements Bayer's precision oncology development portfolio in the areas of pancreatic, colorectal, and lung cancer.
Avista will leverage Forge’s FUEL platform to manufacture AAV for AVST-101, Avista’s lead gene therapy to treat patients with X-linked retinoschisis (XLRS).
Collaboration aims to scale OBD's analytical framework by leveraging Google Cloud's infrastructure.
Certifies ElevateBio’s compliant and scalable manufacturing capabilities for advanced therapies using U.S. and E.U. commercial-level evaluation standards.
The new facility designs, develops and manufactures research-grade pDNA materials to support the cell and gene therapy field.
Sartorius supports commercialization and joint development of solutions based on Nanotein’s NanoSpark platform.
If approved, gepotidacin would offer a new oral option to U.S. patients currently relying on injectable treatments for uncomplicated urogenital gonorrhea.
AVTOZMA IV now aligns with all indications approved for ACTEMRA IV in the United States.
Strategic expansion is designed to advance gene therapy development and manufacturing.
CureVac and GSK will receive $740 million and single-digit royalties on COVID-19 vaccine sales in the U.S. going forward.
CEO Dr. Johannis Willem van Vliet will leave the company shortly as the company transitions to a CDMO.
Meeting Global Injectable Demand
Released By Rovi Pharma Industrial Services
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
